Delivery Order SPE2DB20D2104-SPE2DB25FMGBW
Award Date
1/14/25
Potential Completion Date
1/15/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D3505|SPE2DB24FU2P2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,043.90 firm fixed-price delivery order is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty medication. The contract has a completion date of June 3, 2024 and was awarded on May 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued...
This federal contract award is a delivery order (SPE2DB25FJMJ4) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,368.82 firm fixed-price contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a prescription medication. The contract has a performance period through May 14, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award SPE2DB22D2206 | SPE2DB25FFR00 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML. The $7,728.76 Firm Fixed Price contract has an ultimate completion date of February 18, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,149.12 delivery order contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 23, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, with ID SPE2DB24D2205|SPE2DB25FEBTB, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $63,622.15 firm fixed-price delivery order is for the supply of 4,568,091,779 units of the medication COSENTYX UNOREADY 300 MG PEN 2ML. The contract has a completion date of May 1, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award, with the ID SPE2DB20D2001|SPE2DB25FPMJG, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product, and has a ceiling value of $1,574.56. The contract type is Delivery Order with a Firm Fixed Price pricing model, and the ultimate completion date is April 1, 2025. The...
This federal contract award, identified as SPE2DB20D2104|SPE2DB23FR11X, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $12,293.69, is for the delivery of COSENTYX 300 MG DOSE-2 PENSML, a specialty medication. This is a Firm Fixed Price Delivery Order contract with a completion date of November 17, 2022. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,521.95 Firm Fixed Price delivery order is for the supply of the specialty medication COSENTYX UNOREADY 300 MG PEN 2ML. The contract has an ultimate completion date of April 26, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award, with an ID of SPE2DB24D1006|SPE2DB25FCEKR, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,740.69, is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty pharmaceutical product. This is a firm-fixed-price delivery order contract with a completion date of March 26, 2025. The contract does not have a set-aside designation,...
This federal contract award, with the ID SPE2DB20D1004|SPE2DB25FNFGH, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $7,133.81 firm fixed-price delivery order is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product. The contract has an ultimate completion date of March 4, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that specializes in supplying...